Skip to main content
. 2020 May 21;44(2):685–697. doi: 10.3892/or.2020.7620

Figure 1.

Figure 1.

UBR5 expression pattern and prognostic value in human LCC tissues. (A) Immunohistochemistry staining results demonstrated that UBR5 was overexpressed in LCC specimens compared with non-tumor tissues (magnification, ×200). (B) Immunohistochemical score of UBR5 in LCC and adjacent non-tumor tissues. (C) Increased UBR5 mRNA expression was observed in LCC tissues from the Gene Expression Omnibus database. (D and E) Survival curves demonstrated that increased UBR5 expression was significantly correlated with poor overall survival in patients with LCC (P<0.05). UBR5, ubiquitin protein ligase E3 component n-recognin 5; LCC, laryngeal carcinoma. **P<0.01.